| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058735A2 Ligands of melanocortin receptors and compositions and methods related thereto |
| 07/15/2004 | WO2004058713A1 Differential tumor cytotoxocity compounds and compositions |
| 07/15/2004 | WO2004058705A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases |
| 07/15/2004 | WO2004058201A1 Novel m- phenylendiamine derivatives as coupler components for the colouring of keratin fibres |
| 07/15/2004 | WO2004058164A2 Asthma and allergic inflammation modulators |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004037373A3 CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF β-GLUCOSIDASE |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138488 Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal |
| 07/15/2004 | US20040138448 Synthesis of non-symmetrical sulfamides using burgess-type reagents |
| 07/15/2004 | US20040138309 Factor x inhibitor; anticoagulants |
| 07/15/2004 | US20040138301 Chemical uncouplers for the treatment of obesity |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138233 Novel urokinase inhibitors |
| 07/15/2004 | US20040138228 Novel compounds with analgesic effect |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138146 Methods for preventing or treating cardiac arrhythmia |
| 07/15/2004 | US20040135117 Dichroic dye, composition thereof, and liquid crystal composition and liquid crystal display element containing the same |
| 07/15/2004 | DE10300112A1 Fluorierungsreagenzien und Verfahren zu deren Herstellung Fluorinating reagents and methods for their preparation |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437342A2 Fluorinating reactants and process for their preparation |
| 07/14/2004 | EP1437339A1 Substituted benzoic acid derivatives exhibiting nf-kappa b inhibiting activity |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436271A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 07/14/2004 | EP1436259A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1051973B1 Optic papillary circulation improving agents |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1157388C Piperazine dithioformates compounds, their preparation method and application in cancer-resisting medicine |
| 07/14/2004 | CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds |
| 07/14/2004 | CN1157376C Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 07/14/2004 | CN1157372C Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/14/2004 | CN1157369C Method of preparing granular N-alkyl-ammonium acetonitrile salts |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/13/2004 | US6762330 Making biaryls by reacting a grignard reagent and an aryl halide in the presence of a transition metal complex with a phosphine oxide or phosphine sulfoxide (hp(=s) type) as catalyst |
| 07/13/2004 | US6762306 Chiral ligand |
| 07/13/2004 | US6762300 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 07/13/2004 | CA2118859C Enantiomers of 1-[(4-chlorophenyl)-phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 07/08/2004 | WO2004056764A1 Aromatic derivatives as hiv aspartyl protease inhibitors |
| 07/08/2004 | WO2004056751A1 Antibacterial agents |
| 07/08/2004 | WO2004056750A1 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | WO2004010942A3 Substituted heterocyclic compounds as modulators of the ccr5 receptor |
| 07/08/2004 | US20040133047 Synthesis of 2-aryl-1-naphthol derivatives via a tandem palladium catalyzed arylation and dehydrogenation |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040132786 Differential tumor cytotoxicity compounds and compositions |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/08/2004 | US20040132743 Amorphous form of (-)-[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (levocetirizine dihydrochloride) |
| 07/08/2004 | US20040132742 carboxamide derivatives, e.g., N-[4-Methoxy-3-(4-methylpiperazin-1-yl)phenyl]-N-methyl-4-phenylbenzamide and -Chlorobenzo[b]thiophene-2-carboxylic acid N-(4-methoxy-3-piperazin-1-ylphenyl)-N-methyl amide; 5HT6 receptor antagonists |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132709 Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040131544 Positron emission tomography ; multistage process; medical diagnosis |
| 07/08/2004 | DE10021790B4 Verfahren zur Herstellung von ω-Aminoalkansulfonsäuren und deren Verwendung als Biopuffer Process for the preparation of ω-sulphonic acids and their use as Biopuffer |
| 07/08/2004 | CA2511202A1 Cyclopentil-substituted glutaramide compounds as endopeptidase inhibitors |
| 07/08/2004 | CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | CN1156462C Antipsychotic cyclic N-aralkyl amines |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759511 Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | CA2067433C Preparation of urethane and carbonate products |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004054991A1 Ionic liquids comprising [n(cf3)2]- anions |
| 07/01/2004 | WO2004054967A1 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 07/01/2004 | WO2004033426A3 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 07/01/2004 | WO2004024878A3 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 07/01/2004 | WO2004005513A3 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 07/01/2004 | WO2003086325A3 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 07/01/2004 | US20040127658 Productivity catalysts and microstructure control |
| 07/01/2004 | US20040127574 Aminoethanol derivatives |
| 07/01/2004 | US20040127564 inactivators of antigen-specific T cells; increased half-life |
| 07/01/2004 | US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis |
| 07/01/2004 | US20040127505 Administering 1-alkyl-cyclohexanecarboxylic acid {(1R)-1-cyclohexylmethyl-2-[4-(2-methoxyphenyl)-piperazin-1-yl]-ethyl}-amide for potentiating the action of an inhibitor of serotonin reuptake |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127467 Synthesis of pancratistatin prodrugs |
| 07/01/2004 | US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel |
| 07/01/2004 | US20040126700 Solvent solubility; quality film coatings; workability |
| 07/01/2004 | DE10260820A1 Neue Kupplerkomponenten New Kupplerkomponenten |
| 07/01/2004 | CA2506685A1 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |